Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Michihiro Mitobe"'
Autor:
Tamehito Onoe, Satoshi Hara, Kazunori Yamada, Takeshi Zoshima, Ichiro Mizushima, Kiyoaki Ito, Takayasu Mori, Shoichiro Daimon, Hiroaki Muramoto, Maki Shimizu, Akira Iguchi, Akihiro Kuma, Yoshifumi Ubara, Michihiro Mitobe, Hiroaki Tsuruta, Nao Kishimoto, Junko Imura, Tadashi Konoshita, Mitsuhiro Kawano
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare hereditary disease caused by a variety of genetic mutations. Carriers of a mutation in the responsible genes are at risk of reaching end-stage kidney disease t
Externí odkaz:
https://doaj.org/article/7344569a1e874d1799356d62db07d28f
Autor:
Masayo Sato, Hiroshi Kataoka, Yusuke Ushio, Shun Manabe, Saki Watanabe, Taro Akihisa, Shiho Makabe, Rie Yoshida, Naomi Iwasa, Michihiro Mitobe, Norio Hanafusa, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki
Publikováno v:
Medicines, Vol 7, Iss 3, p 13 (2020)
Background: Serum phosphate levels, which are associated with the progression of renal dysfunction in chronic kidney disease, in patients with autosomal dominant polycystic kidney disease (ADPKD) are lower than those in patients with other kidney dis
Externí odkaz:
https://doaj.org/article/b616ddaa12cc4f5395f0107d0a76f799
Autor:
Tadashi Sofue, Akinari Sekine, Kazuhiko Tsuruya, Michihiro Mitobe, Toshio Mochizuki, Yosuke Shimada, Shigeo Horie, Shinya Nakatani, Ken Tsuchiya, Eiji Ishimura, Yoshifumi Ubara, Kazushige Hanaoka, Satoru Muto, Ichiei Narita, Satoshi Tanaka, Shoichi Maruyama, Hiroshi Kataoka, Kiyotaka Uchiyama, Kikuo Nutahara, Saori Nishio, Tatsuya Suwabe
Publikováno v:
Clinical and Experimental Nephrology. 25:970-980
Factors affecting decline in renal function and cyst growth in patients with autosomal polycystic kidney disease (ADPKD) are not fully described, particularly in Japan. This was the first multi-facility, prospective, observational cohort study conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1533d37b08f7b84238dd81c383875db1
https://doi.org/10.1007/s10157-021-02068-x
https://doi.org/10.1007/s10157-021-02068-x
Autor:
Yoshiaki Usui, Kosei Matsue, Kazuho Honda, Shota Ogura, Shigeru Horita, Hideaki Oda, Michihiro Mitobe, Sekiko Taneda, Kosaku Nitta
Publikováno v:
Kidney International Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f8183acdfc3e01939e5150cfaccc32
https://doi.org/10.1016/j.ekir.2019.09.012
https://doi.org/10.1016/j.ekir.2019.09.012
Autor:
Kengo Furuichi, Kenichiro Miura, Keiji Shimazu, Hiroki Hayashi, Taketsugu Hama, Daisuke Ichikawa, Sumi Hidaka, Eiji Ishikawa, Soshiro Ogata, Koichi Seta, Kiyotaka Uchiyama, Kazushige Hanaoka, Eri Koshi-Ito, Shigeo Horie, Yoshikatsu Kaneko, Mahiro Kurashige, Shinya Nakatani, Ichiei Narita, Ken Tsuchiya, Shiho Makabe, Toshio Mochizuki, Hirayasu Kai, Hiroshi Kataoka, Akinari Sekine, Haruna Kawano, Hirokazu Okada, Satoru Muto, Koichi Nakanishi, Tatsuya Suwabe, Saori Nishio, Michihiro Mitobe
Publikováno v:
Clinical and experimental nephrology. 25(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41efa9c382dc06811f981f1a5a566c5d
https://pubmed.ncbi.nlm.nih.gov/34564792
https://pubmed.ncbi.nlm.nih.gov/34564792
Autor:
Shiho Makabe, Toshio Mochizuki, Kosaku Nitta, Michihiro Mitobe, Hiroshi Kataoka, Toru Furukawa, Ken Tsuchiya, Taro Akihisa, Atsuko Teraoka, Hiroyuki Akagawa, Masayo Sato
Publikováno v:
Clinical and Experimental Nephrology. 23:1022-1030
Autosomal dominant polycystic kidney disease (ADPKD), one of the most common hereditary kidney diseases, causes gradual growth of cysts in the kidneys, leading to renal failure. Owing to the advanced technology of next-generation sequencing (NGS), ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa6192bdfad1d5c8d7063c21662f0ec
https://doi.org/10.1007/s10157-019-01736-3
https://doi.org/10.1007/s10157-019-01736-3
Autor:
Tadashi Konoshita, Junko Imura, Hiroaki Muramoto, Michihiro Mitobe, Kiyoaki Ito, Ichiro Mizushima, Hiroaki Tsuruta, Mitsuhiro Kawano, Akira Iguchi, Shoichiro Daimon, Tamehito Onoe, Satoshi Hara, Takeshi Zoshima, Takayasu Mori, Nao Kishimoto, Akihiro Kuma, Maki Shimizu, Kazunori Yamada, Yoshifumi Ubara
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
BMC Nephrology
BMC Nephrology
Background Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare hereditary disease caused by a variety of genetic mutations. Carriers of a mutation in the responsible genes are at risk of reaching end-stage kidney disease typically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2fcd5a1507914d278f1b788f83a9429
https://doi.org/10.1186/s12882-020-02169-x
https://doi.org/10.1186/s12882-020-02169-x
Autor:
Ken Tsuchiya, Masayo Sato, Rie Yoshida, Hinata Fukuoka, Michihiro Mitobe, Atsuko Teraoka, Shun Manabe, Toshio Mochizuki, Hiroshi Kataoka, Taro Akihisa, Yusuke Ushio, Shiho Makabe, Kosaku Nitta
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 1
Journal of Clinical Medicine, Vol 9, Iss 1, p 146 (2020)
Volume 9
Issue 1
Journal of Clinical Medicine, Vol 9, Iss 1, p 146 (2020)
Autosomal dominant polycystic kidney disease (ADPKD) patients with PKD1 mutations, particularly those with truncating mutations, show poor prognosis. However, the differences in disease progression with different mutation types are unclear. Here, a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::325461729e2cf84c6e1e78b1eb9b286f
Autor:
Ken Tsuchiya, Yumi Aoyama, Shiho Makabe, Hiroshi Kataoka, Toshio Mochizuki, Michihiro Mitobe, Kosaku Nitta
Publikováno v:
Clinical and Experimental Nephrology. 22:1079-1087
In 2014, tolvaptan, a vasopressin receptor antagonist, was approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD) in Japan. Clinical trials of tolvaptan revealed frequent occurrence of the liver function abnormality. Accor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21367b54369357eff033b942710442b5
https://doi.org/10.1007/s10157-018-1545-7
https://doi.org/10.1007/s10157-018-1545-7
Autor:
Anri Sawada, Kentaro Kawasoe, Nobuyuki Amemiya, Shigeru Horita, Toshio Mochizuki, Takahito Moriyama, Yasuko Ito, Takahiro Inoue, Masayo Sato, Takafumi Akanuma, Michihiro Mitobe, Tomo Suzuki, Shiho Makabe, Mamiko Ohara, Kosaku Nitta, Shun Manabe, Taro Akihisa, Hiroshi Kataoka, Kazuho Honda, Katsuomi Matsui, Keiko Kawachi
Publikováno v:
Medicine. 98:e14014
Rationale:Adult-onset hepatitis B virus-associated membranoproliferative glomerulonephritis (HBV-MPGN) is generally refractory, and an effective treatment for this condition has not been established. The indications for steroids in HBV-MPGN are an im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75ec05b9c18af58445d79ada51c82744
https://doi.org/10.1097/md.0000000000014014
https://doi.org/10.1097/md.0000000000014014